1.
Antibiot Khimioter
; 60(7-8): 23-6, 2015.
Article
in Russian
| MEDLINE
| ID: mdl-26863739
ABSTRACT
The data on the pharmacoeconomic research of the use of Remaxol in treatment of drug-associated liver injury due to the chemotherapy in cancer patients are presented. The costs-efficiency method was applied to two groups of the patients with drug-associated liver injury treated according to different schemes. The research showed economical benefits of the Remaxol use.